The high-dose,
low-frequency interferon

for the treatment of relapsing multiple sclerosis (MS)1,2


The ADVANCE clinical trial examined 3 key measures of disease activity

Review the data
Safety and tolerability1

Review the well-established safety profile and strategies to address tolerability

See safety
One injection every 2 weeks1

Find out if dosing with PLEGRIDY may fit into your patient’s routine

Explore dosing and administration
Getting started

Get your patients started on therapy with the PLEGRIDY Start Form

Download Start Form
Streamline the process and support patient adherence

myBiogen is an online resource for starting and keeping patients on therapy

Sign up at
Support for your patients is here

Biogen Case Managers and Nurse Educators are here to help your patients start and continue on PLEGRIDY

Get support today